Nasopharyngeal carcinoma secondary prevention: Difference between revisions
No edit summary |
|||
Line 12: | Line 12: | ||
===Follow up after treatment=== | ===Follow up after treatment=== | ||
After treatment, patients with nasopharyngeal carcinoma should follow up for prevention of second malignancy. Follow up includes: | After treatment, patients with nasopharyngeal carcinoma should follow up for prevention of second malignancy. Follow up includes: | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center | |||
|valign=top| | |||
|+ | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Follow up}} | |||
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Description}} | |||
== | |- | ||
*CT Scan | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | ||
*MRI | :Physical exam | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Every 1-3 months for 1st year after treatment | |||
*Every 2-6 months for 2nd year after treatment | |||
*Every 4-8 months for 3-5 years after treatment | |||
*Every year after 5 years | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | |||
:Nasendoscopy | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*After radiation therapy | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | |||
:Scanning | |||
:*CT Scan | |||
:*MRI | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
Scans are performed at routine intervals as follows: | Scans are performed at routine intervals as follows: | ||
*Baseline scanning is done in 3-6 months after treatment, further scans are scheduled based on finding of physical exam and symptoms experienced by the patient | *Baseline scanning is done in 3-6 months after treatment, further scans are scheduled based on finding of physical exam and symptoms experienced by the patient | ||
*Scanning for asymptomatic patients is not encouraged | *Scanning for asymptomatic patients is not encouraged | ||
= | |- | ||
Thyroid stimulating hormone testing every 12 months if neck is exposed to radiation therapy | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | ||
= | :Thyroid hormone testing | ||
Only implicated if oral cavity is exposed to radiations | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Thyroid stimulating hormone testing every 12 months if neck is exposed to radiation therapy | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | |||
:Dental screening | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Only implicated if oral cavity is exposed to radiations | |||
|- | |||
|} | |||
==References== | ==References== |
Revision as of 12:45, 29 September 2015
Nasopharyngeal carcinoma Microchapters |
Differentiating Nasopharyngeal carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Nasopharyngeal carcinoma secondary prevention On the Web |
American Roentgen Ray Society Images of Nasopharyngeal carcinoma secondary prevention |
Risk calculators and risk factors for Nasopharyngeal carcinoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
EBV-associated antibodies may be helpful for secondary prevention of nasopharyngeal carcinoma.
Secondary Prevention
EBV-associated antibodies may be helpful for secondary prevention of nasopharyngeal carcinoma.
Follow up after treatment
After treatment, patients with nasopharyngeal carcinoma should follow up for prevention of second malignancy. Follow up includes:
Follow up | Description |
---|---|
|
|
|
|
|
Scans are performed at routine intervals as follows:
|
|
|
|
|